2024 Q3 Form 10-Q Financial Statement

#000077240624000057 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $541.9M $374.0M
YoY Change 12.64% 17.98%
Cost Of Revenue $259.3M $185.1M
YoY Change 10.58% 17.43%
Gross Profit $282.6M $188.9M
YoY Change 14.6% 18.53%
Gross Profit Margin 52.15% 50.51%
Selling, General & Admin $37.81M $36.77M
YoY Change 10.17% 3.93%
% of Gross Profit 13.38% 19.46%
Research & Development $112.9M $105.4M
YoY Change 8.37% -0.8%
% of Gross Profit 39.96% 55.77%
Depreciation & Amortization $12.62M $12.36M
YoY Change 7.85% 3.5%
% of Gross Profit 4.47% 6.54%
Operating Expenses $150.7M $142.1M
YoY Change 7.02% 0.38%
Operating Profit $131.9M $46.79M
YoY Change 24.68% 162.98%
Interest Expense $8.818M $8.170M
YoY Change 138.32% 77.61%
% of Operating Profit 6.69% 17.46%
Other Income/Expense, Net $19.00K $1.609M
YoY Change -127.14% 326.79%
Pretax Income $140.0M $56.60M
YoY Change 27.97% 148.59%
Income Tax $37.90M $14.50M
% Of Pretax Income 27.07% 25.62%
Net Earnings $102.1M $42.10M
YoY Change 35.45% 169.84%
Net Earnings / Revenue 18.85% 11.25%
Basic Earnings Per Share $1.92 $0.79
Diluted Earnings Per Share $1.83 $0.76
COMMON SHARES
Basic Shares Outstanding 53.41M shares 53.57M shares
Diluted Shares Outstanding 55.80M shares 55.67M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $478.3M $517.0M
YoY Change 53.09% 33.22%
Cash & Equivalents $445.8M $491.4M
Short-Term Investments $32.50M $25.68M
Other Short-Term Assets $29.45M $29.09M
YoY Change -58.69% -83.24%
Inventory $271.8M $232.6M
Prepaid Expenses $49.59M $48.28M
Receivables $324.1M $190.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.225B $1.102B
YoY Change 11.67% 5.06%
LONG-TERM ASSETS
Property, Plant & Equipment $168.3M $171.0M
YoY Change -1.63% -41.61%
Goodwill $435.9M $435.9M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $228.3M $227.5M
YoY Change 470.76% 498.3%
Other Assets $53.29M $60.55M
YoY Change 20.98% -70.42%
Total Long-Term Assets $1.131B $1.164B
YoY Change 12.27% 15.47%
TOTAL ASSETS
Total Short-Term Assets $1.225B $1.102B
Total Long-Term Assets $1.131B $1.164B
Total Assets $2.356B $2.266B
YoY Change 11.96% 10.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $91.90M $77.56M
YoY Change 5.22% 2.13%
Accrued Expenses $110.7M $96.63M
YoY Change 13.11% 10.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $229.3M $201.7M
YoY Change 13.96% -0.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $24.00K $193.0K
YoY Change -99.67% -99.9%
Total Long-Term Liabilities $198.7M $216.3M
YoY Change 1.96% 9.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $229.3M $201.7M
Total Long-Term Liabilities $198.7M $216.3M
Total Liabilities $428.0M $418.0M
YoY Change 8.06% 4.55%
SHAREHOLDERS EQUITY
Retained Earnings $107.2M $58.59M
YoY Change -8940.31% -274.27%
Common Stock $1.820B $1.792B
YoY Change 6.24% 5.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.928B $1.848B
YoY Change
Total Liabilities & Shareholders Equity $2.356B $2.266B
YoY Change 11.96% 10.16%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $102.1M $42.10M
YoY Change 35.45% 169.84%
Depreciation, Depletion And Amortization $12.62M $12.36M
YoY Change 7.85% 3.5%
Cash From Operating Activities $8.231M $87.16M
YoY Change -136.26% -318.93%
INVESTING ACTIVITIES
Capital Expenditures $2.740M $9.990M
YoY Change -67.76% -18.85%
Acquisitions
YoY Change
Other Investing Activities -$2.742M -$56.41M
YoY Change 357.0% 2327.45%
Cash From Investing Activities -$5.482M -$66.56M
YoY Change -40.41% 354.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -48.34M -$32.02M
YoY Change 13.48% -17.89%
NET CHANGE
Cash From Operating Activities 8.231M $87.16M
Cash From Investing Activities -5.482M -$66.56M
Cash From Financing Activities -48.34M -$32.02M
Net Change In Cash -45.59M -$11.41M
YoY Change -38.8% -87.79%
FREE CASH FLOW
Cash From Operating Activities $8.231M $87.16M
Capital Expenditures $2.740M $9.990M
Free Cash Flow $5.491M $77.17M
YoY Change -117.6% -248.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-450000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-358000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-20000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-75000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-4000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
185101000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
157629000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
188925000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
159387000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
105363000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106215000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36770000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35379000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
142133000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
141594000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
46792000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17793000 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
8420000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
4818000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1609000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
377000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56603000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22770000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14508000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7170000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
42095000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53433000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54862000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55665000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56631000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
42095000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12359000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11941000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
21385000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
22715000 usd
CY2024Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5897000 usd
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9411000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1334000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27601000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35560000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5318000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
67506000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
502764000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
445784000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
218000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
218000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-358000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41454000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15134000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
42095000 usd
CY2024Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1104000 usd
CY2024Q2 crus Increase Decrease In Advances On Inventory Purchases
IncreaseDecreaseInAdvancesOnInventoryPurchases
-12354000 usd
CY2023Q2 crus Increase Decrease In Advances On Inventory Purchases
IncreaseDecreaseInAdvancesOnInventoryPurchases
0 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5459000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-8101000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12037000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10278000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
30102000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
20079000 usd
CY2024Q2 crus Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
0 usd
CY2023Q2 crus Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
3166000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
87161000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39813000 usd
CY2024Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
12646000 usd
CY2023Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
11048000 usd
CY2024Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
69060000 usd
CY2023Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13372000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9990000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12310000 usd
CY2024Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
155000 usd
CY2023Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66559000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14634000 usd
CY2024Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10196000 usd
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
560000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1219000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1047000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40992000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38504000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32015000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38991000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11413000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93438000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
491351000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
352346000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1658282000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-450000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-482000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
38855000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22715000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1656794000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1817014000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
42095000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-283000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-358000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8978000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
41201000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21385000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1847630000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
254459000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
91000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1343000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
253207000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1300000 usd
CY2024Q2 crus Available For Sale Securities Amortized Cost On Gross Unrealized Losses
AvailableForSaleSecuritiesAmortizedCostOnGrossUnrealizedLosses
224500000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
21800000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
300000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
198045000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
115000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1008000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
197152000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000000.0 usd
CY2024Q1 crus Available For Sale Securities Amortized Cost On Gross Unrealized Losses
AvailableForSaleSecuritiesAmortizedCostOnGrossUnrealizedLosses
172100000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
25000000.0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
300000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
25881000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
25680000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
24071000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
23778000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
228578000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
227527000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
173974000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
173374000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
254459000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
253207000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
198045000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
197152000 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q2 us-gaap Lines Of Credit Fair Value Disclosure
LinesOfCreditFairValueDisclosure
0 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
253207000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
439465000 usd
CY2024Q2 us-gaap Number Of Foreign Currency Derivatives Held
NumberOfForeignCurrencyDerivativesHeld
1 derivativecontract
CY2024Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
11300000 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
190079000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
162478000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
190079000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
162478000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
130464000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
130842000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
102102000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
96406000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
232566000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
227248000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374026000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317016000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
374026000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
317016000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
2300000 usd
crus Restructuring Charges Recovery
RestructuringChargesRecovery
400000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
1000000.0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56603000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22770000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14508000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7170000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14500000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7200000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.256
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32100000 usd
CY2024Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
9900000 usd
CY2024Q2 us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
168300000 usd
CY2024Q2 crus Income Tax Examination Estimate Of Possible Loss Penalties Expense
IncomeTaxExaminationEstimateOfPossibleLossPenaltiesExpense
63700000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
42095000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
15600000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53433000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54862000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2232000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1769000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55665000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56631000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
259000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
347000 shares
CY2021Q3 crus Payments For Purchase Commitment Capacity Reservation Fee
PaymentsForPurchaseCommitmentCapacityReservationFee
60000000 usd
CY2024Q2 crus Unamortized Capacity Reservation Fees
UnamortizedCapacityReservationFees
29000000 usd
CY2021Q3 crus Payments For Purchase Commitments Prepaid Wafers
PaymentsForPurchaseCommitmentsPrepaidWafers
195000000 usd
CY2024Q2 crus Purchase Commitments Prepaid And Long Term Prepaid Wafers
PurchaseCommitmentsPrepaidAndLongTermPrepaidWafers
135000000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
200000 shares
CY2024Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1500000 usd
CY2024Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 crus Number Of Product Lines
NumberOfProductLines
2 product_line
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000772406-24-000057-index-headers.html Edgar Link pending
0000772406-24-000057-index.html Edgar Link pending
0000772406-24-000057.txt Edgar Link pending
0000772406-24-000057-xbrl.zip Edgar Link pending
crus-20240629.htm Edgar Link pending
crus-20240629.xsd Edgar Link pending
crus-20240629_cal.xml Edgar Link unprocessable
crus-20240629_def.xml Edgar Link unprocessable
crus-20240629_lab.xml Edgar Link unprocessable
crus-20240629_htm.xml Edgar Link completed
crus-20240629_pre.xml Edgar Link unprocessable
ex311-crus8624.htm Edgar Link pending
ex312-crus8624.htm Edgar Link pending
ex321-crus8624.htm Edgar Link pending
ex322-crus8624.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending